Venetoclax is under clinical development by AbbVie and currently in Phase II for Refractory Acute Myeloid Leukemia.

Venetoclax is under clinical development by AbbVie and currently in Phase II for Relapsed Acute Myeloid Leukemia.

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

At the 8-cell stage of mouse embryo development, the coordination between DNA unwinding and replication appears to improve. © ...